Cisplatin, 5-fluorouracil, and cetuximab (PFE) with or...

Annals of Oncology 2014 / 03 Vol. 25; Iss. 3

Cisplatin, 5-fluorouracil, and cetuximab (PFE) with or without cilengitide in recurrent/metastatic squamous cell carcinoma of the head and neck: results of the randomized phase I/II ADVANTAGE trial (phase II part)

Vermorken, J. B., Peyrade, F., Krauss, J., Mesia, R., Remenar, E., Gauler, T. C., Keilholz, U., Delord, J. P., Schafhausen, P., Erfan, J., Brummendorf, T. H., Iglesias, L., Bethe, U., Hicking, C., Cle
How much do you like this book?
What’s the quality of the file?
Download the book for quality assessment
What’s the quality of the downloaded files?
Volume:
25
Language:
english
Journal:
Annals of Oncology
DOI:
10.1093/annonc/mdu003
Date:
March, 2014
File:
PDF, 233 KB
english, 2014
Conversion to is in progress
Conversion to is failed